Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis

[1] Fisher HP(2004)Pathogenesis of carcinoma of the papilla of Vater J Hepatobil Pancreat Surg 11 301-309

[2] Zhou H(1999)Differences in mucus and K-ras mutation in relation to phenotypes of tumors of papilla of Vater Cancer 86 596-607

[3] Matsubayashi H(1994)Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater Jpn J Cancer Res 85 161-166

[4] Watanabe H(2004)Carcinoma of the ampullary of Vater: comparative histologic/immunohistochemical classification and follow-up Am J Surg Pathol 28 875-882

[5] Yamaguchi T(2005)Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2 Am J Surg Pathol 29 359-367

[6] Ajioka Y(2004)Differentiation pathways in duodenal and ampullary carcinoma: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinoma Virchow Arch 444 536-541

[7] Nishikura K(2000)Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder Pathol Lab Med 124 1196-1200

[8] Kijima H(2001)Cytokeratin 7, 17 and 20 reactivity in pancreatic and ampullary of Vater adenocarcinomas Am J Clin Pathol 115 695-702

[9] Saito T(2001)The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma Am J Surg Pathol 25 942-948

[10] Kimura W(1999)Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients Arch Surg 134 526-532

[1] Fisher HP(2004)Pathogenesis of carcinoma of the papilla of Vater J Hepatobil Pancreat Surg 11 301-309

[2] Zhou H(1999)Differences in mucus and K-ras mutation in relation to phenotypes of tumors of papilla of Vater Cancer 86 596-607

[3] Matsubayashi H(1994)Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater Jpn J Cancer Res 85 161-166

[4] Watanabe H(2004)Carcinoma of the ampullary of Vater: comparative histologic/immunohistochemical classification and follow-up Am J Surg Pathol 28 875-882

[5] Yamaguchi T(2005)Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2 Am J Surg Pathol 29 359-367

[6] Ajioka Y(2004)Differentiation pathways in duodenal and ampullary carcinoma: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinoma Virchow Arch 444 536-541

[7] Nishikura K(2000)Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder Pathol Lab Med 124 1196-1200

[8] Kijima H(2001)Cytokeratin 7, 17 and 20 reactivity in pancreatic and ampullary of Vater adenocarcinomas Am J Clin Pathol 115 695-702

[9] Saito T(2001)The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma Am J Surg Pathol 25 942-948

[10] Kimura W(1999)Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients Arch Surg 134 526-532